• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.76% Nasdaq Down 1.17%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    2.70 Down 0.05(1.82%) 3:21PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.75
    Open:2.70
    Bid:2.72 x 1400
    Ask:2.73 x 9800
    1y Target Est:7.38
    Beta:0.306574
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:2.67 - 2.77
    52wk Range:2.54 - 6.28
    Volume:697,738
    Avg Vol (3m):2,735,010
    Market Cap:654.05M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 1.82%654.05M
    GSKDown 2.36%95.86B
    OREXDown 5.45%326.02M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.50
    Quarterly EPS Est (Sep-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback